BIOMARKER:

FGFR3 overexpression

Entrez ID:

Related biomarkers:

‹

›

FGFR3 overexpression FGFR3 overexpression	Urothelial Cancer Urothelial Cancer	atezolizumab + BAY1163877 Sensitive: C2 – Inclusion Criteria
FGFR3 overexpression FGFR3 overexpression	Head and Neck Cancer Head and Neck Cancer	BAY1163877 Sensitive: C3 – Early Trials
FGFR3 overexpression FGFR3 overexpression	Lung Non-Small Cell Squamous Cancer Lung Non-Small Cell Squamous Cancer	BAY1163877 Resistant: C3 – Early Trials
FGFR3 overexpression FGFR3 overexpression	Bladder Cancer Bladder Cancer	TAS 120 Sensitive: D – Preclinical
FGFR3 overexpression FGFR3 overexpression	Squamous Cell Carcinoma of Head and Neck SCCHN	BAY1163877 Sensitive: D – Preclinical
FGFR3 overexpression FGFR3 overexpression	Squamous Cell Carcinoma of Head and Neck SCCHN	infigratinib Sensitive: D – Preclinical